26 July 2012 - Pharmaceutical products company Eli Lilly and Company (NYSE:LLY) and Boehringer Ingelheim a pharmaceutical company, announced on Wednesday the receipt of Marketing Authorisation from the European Commission for Jentadueto (linagliptin/metformin hydrochloride) tablets, a medicine combi...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up